Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/20
End: 10/30/22
Due: 10/30/23
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 03/31/17
Due: 03/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease | NCT03687476 | Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company | user2@example.com | None | 2020-05-31 | 2022-10-30 | 2023-10-30 | - | - | 2025-07-14 |
| Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease | NCT01747135 | Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company | user2@example.com | None | 2013-01-31 | 2017-03-31 | 2018-03-31 | - | - | 2025-07-14 |